We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Scans See Increased Use in "Severe” H1N1 Cases

By HospiMedica International staff writers
Posted on 19 Feb 2010
Published reports on the usefulness of computed tomography (CT) scans for complicated H1N1 cases have spurred use of these procedures in U.S. More...
hospitals.

According to healthcare market research publisher Kalorama Information (New York, NY, USA), this creates a pathway of diagnostics for physicians and overall is a positive sign not only for the technology but also for companies making chemical agents for procedures. In the recent report, Kalorama estimates the sale of CT contrast agents in the United States at US$880 million in 2009.

CT utilizes energy waves to image the human body and renders an image in three-dimensional (3D) from a series of two-dimensional X-rays. Although it is not completely novel for a CT scan to be ordered for flu cases where pain is reported, a new study suggests the technology is preferable to X-rays. The study, conducted in coordination with the University of Michigan (Ann Arbor, USA) Health Service and published in the December 2009 issue of the American Journal of Roentgenology (AJR), has given new support to the modality's usage in the most severe cases of the H1N1 flu virus.

The study, which consisted of a review of thousands of patient records, provided several important findings: that H1N1 flu can cause pulmonary embolism, that pulmonary embolism (PE) may be responsible for H1N1 deaths, and that physician evaluation of patients diagnosed with respiratory complications via contrast-enhanced CT scan is recommended. The study did not establish the technology as a test for detecting the virus itself. The primary test for H1N1 is an immunoassay that can detect antigens for specific strains of flu. But the study supports using the CT scan as an adjunctive tool after other tests are performed, to determine if the patient's flu is a major case.

"This is one of many areas where the agent-enhanced CT scan is playing a supporting role in diagnosis,” said Bruce Carlson, publisher of Kalorama Information. "Physicians are increasingly comfortable with computed tomography when a diagnosis is not clear from other modalities.”

Trauma, pediatric health, vascular imaging, and cardiac imaging are among the areas where CT scans are employed, and other areas are being investigated. Kalorama estimates that over 54.5 million imaging procedures were performed in the United States in 2009, most requiring some kind of contrast agent.

Kalorama Information supplies independent market research in the life sciences, as well as custom research services.

Related Links:
Kalorama Information


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Glucose Meter
StatStrip®
New
Gold Member
Radiology Monitor
MDNC-12130 Barco Nio Fusion 12MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.